Gemfibrozil and Aromasin drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Gemfibrozil and Aromasin. Common interactions include anxiety among females.
The phase IV clinical study analyzes what interactions people who take Gemfibrozil and Aromasin have. It is created by eHealthMe based on reports of 40 people who take Gemfibrozil and Aromasin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
40 people who take Gemfibrozil and Aromasin together, and have interactions are studied.
What is Gemfibrozil?
Gemfibrozil has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 17,437 Gemfibrozil users for its effectiveness, alternative drugs and more.
What is Aromasin?
Aromasin has active ingredients of exemestane. It is often used in breast cancer. eHealthMe is studying from 12,129 Aromasin users for its effectiveness, alternative drugs and more.
Number of Gemfibrozil and Aromasin reports submitted per year:
Common Gemfibrozil and Aromasin drug interactions by gender *:
- Rotator cuff syndrome
- Blood creatinine increased
- Bone disorder
- Ankle fracture
Common Gemfibrozil and Aromasin drug interactions by age *:
- Back pain
- Biliary colic
- Bipolar i disorder
- Bone swelling
- Bundle branch block left
- Burning sensation
- Chest pain
- Rotator cuff syndrome
- Blood creatinine increased
- Ankle fracture
- Metastases to liver
Common conditions people have *:
- Hypercalcaemia (elevated calcium (ca+) level in the blood): 15 people, 37.50%
- High Blood Pressure: 15 people, 37.50%
- Anaemia (lack of blood): 11 people, 27.50%
- Urticaria (rash of round, red welts on the skin that itch intensely): 5 people, 12.50%
- Breast Cancer Female: 3 people, 7.50%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.00%
- Bipolar Disorder (mood disorder): 2 people, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take Gemfibrozil and Aromasin?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of the 2 drugs:
- Gemfibrozil (17,437 reports)
- Aromasin (12,129 reports)
Browse all drug interactions of Gemfibrozil and Aromasin:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Gemfibrozil side effects:
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 2,379 reports
- Acute kidney failure: 1,897 reports
- Stress and anxiety: 1,811 reports
- Depression: 1,639 reports
- Obstructive uropathy (a blockage that prevents urine from leaving your kidneys): 1,091 reports
- Weakness: 1,087 reports
- Pain: 932 reports
- Fatigue (feeling of tiredness): 921 reports
Browse all side effects of Gemfibrozil:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Aromasin side effects:
- Fatigue (feeling of tiredness): 1,308 reports
- Pain: 1,222 reports
- Joint pain: 1,214 reports
- Stress and anxiety: 899 reports
- Weakness: 888 reports
- Breathing difficulty: 868 reports
Browse all side effects of Aromasin:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Gemfibrozil interactions:
- Gemfibrozil and Metformin: 3,155 reports
- Gemfibrozil and Lisinopril: 2,937 reports
- Gemfibrozil and Aspirin: 2,934 reports
- Gemfibrozil and Omeprazole: 1,887 reports
- Gemfibrozil and Simvastatin: 1,777 reports
- Gemfibrozil and Baycol: 1,773 reports
- Gemfibrozil and Furosemide: 1,644 reports
- Gemfibrozil and Gabapentin: 1,559 reports
- Gemfibrozil and Atenolol: 1,446 reports
- Gemfibrozil and Amlodipine: 1,367 reports
Browse all interactions between Gemfibrozil and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Aromasin interactions:
- Aromasin and Zometa: 1,599 reports
- Aromasin and Afinitor: 1,550 reports
- Aromasin and Femara: 1,007 reports
- Aromasin and Arimidex: 914 reports
- Aromasin and Faslodex: 848 reports
- Aromasin and Xeloda: 806 reports
- Aromasin and Aredia: 707 reports
- Aromasin and Aspirin: 646 reports
- Aromasin and Taxotere: 642 reports
- Aromasin and Ibrance: 554 reports
Browse all interactions between Aromasin and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on gemfibrozil and exemestane (the active ingredients of Gemfibrozil and Aromasin, respectively), and Gemfibrozil and Aromasin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Gemfibrozil and Aromasin.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lincomycin and Prochlorperazine Edisylate drug interaction - 4 seconds ago
- Prazepam and Pindolol drug interaction - 11 seconds ago
- Yervoy and Peginterferon drug interaction - 16 seconds ago
- Propoxyphene Hydrochloride and Hypersensitivity - 16 seconds ago
- Dalvance and Lopressor drug interaction - 21 seconds ago
- Remeron and Integrilin drug interaction - 21 seconds ago
- Ambien and Pancreatitis Aggravated - 23 seconds ago
- Levothroid and Hyzaar drug interaction - 25 seconds ago
- Lisinopril and Erelzi drug interaction - 25 seconds ago
- Wellbutrin and Macrocytosis - 29 seconds ago